Notice NOT-CA-21-036 from the NIH Guide for Grants and Contracts

Notice NOT-EY-21-001 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-040 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-039 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-038 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-037 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-21-030 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs. Applicants should have a working assay or device prototype (not necessarily already capable of cancer applications). The U01 project includes studies to both adapt this technology as well as demonstrate technical functionality and clinical performance for use of the device or assay in specific LMIC settings by meeting objective performance milestones followed by improvements and validations of the technologies in the LMIC settings. Projects proposed in response to this FOA will require multidisciplinary efforts to succeed; therefore, all applicant teams must include expertise in engineering/assay/treatment development, oncology, global healthcare delivery, and business development. Investigators responding to this FOA must consider affordability and cost-effectiveness as well as usability at the point-of-need as part of their design criteria. This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program.

Funding Opportunity RFA-AI-21-007 from the NIH Guide for Grants and Contracts. To support the design of novel tuberculosis (TB) vaccine candidates that exploit innovative approaches and their advancement into preclinical animal model testing. This funding opportunity will use a milestone driven, biphasic award mechanism to fund high risk/exploratory research. Transition to the second phase depends on the successful completion of milestones.

Funding Opportunity RFA-AI-21-022 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide an opportunity for the Regional Biocontainment Laboratories (RBLs) established by the National Institute of Allergy and Infectious Diseases (NIAID) to request support for upgrades to existing facilities and building systems to facilitate the conduct of biomedical research on infectious diseases, including infectious disease outbreaks.

Notice NOT-OD-21-067 from the NIH Guide for Grants and Contracts

Notice NOT-HG-21-022 from the NIH Guide for Grants and Contracts

Notice NOT-GM-21-031 from the NIH Guide for Grants and Contracts

Notice NOT-EB-21-004 from the NIH Guide for Grants and Contracts

Notice NOT-EB-21-005 from the NIH Guide for Grants and Contracts

Notice NOT-EB-21-002 from the NIH Guide for Grants and Contracts

Notice NOT-EB-21-003 from the NIH Guide for Grants and Contracts

Notice NOT-DK-21-013 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-146 from the NIH Guide for Grants and Contracts. The goal of the Undergraduate Research Training Initiative for Student Enhancement (U-RISE) program is to develop a diverse pool of undergraduates who complete their baccalaureate degree, and transition into and complete biomedical, research-focused higher degree programs (e.g., Ph.D. or M.D./Ph.D). This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring, and career development elements to prepare trainees for the completion of research-focused higher degree programs in biomedical fields. This program is limited to applications from training programs at research-active institutions (i.e., those with a 3-year average of NIH Research Project Grant funding less than $7.5 million total costs).

Notice NOT-CA-21-035 from the NIH Guide for Grants and Contracts

Notice NOT-HD-21-009 from the NIH Guide for Grants and Contracts